🔥
5d • DAILY CLASS
MEDICATION MONDAY - MYTH: DIABETES MEDICATIONS TREAT DIABETES
Damn, she's going to do it again. Say what?
The Diabetes Secret No One Talks About
Most people think diabetes meds treat diabetes.
But here’s the part no one ever says out loud:
They don’t. They treat a number.
And the number isn’t the disease.
Let me explain, without the medical jargon.
MYTH: “Diabetes Medications Treat Diabetes.”
They treat glucose. The disease is something else entirely.
Most people don’t realize this, but if diabetes were simply “high blood sugar,” we would have cured it decades ago. We have dozens of medications that lower glucose, aggressively, effectively, impressively on paper.
And yet the disease keeps progressing.
Why?
Because Type 2 diabetes is not a glucose problem. It’s a metabolic communication problem.
And medications don’t repair the communication system.
Let’s break this open.
What Diabetes Actually Is
Type 2 diabetes is fundamentally a disorder of:
- impaired insulin signaling
- mitochondrial dysfunction
- chronic inflammation
- metabolic inflexibility
- disrupted nutrient‑hormone communication
- loss of muscle glucose uptake
High glucose is the symptom, not the cause.
It’s the smoke, not the fire.
What Diabetes Medications Actually Do
Most medications fall into one of these categories:
- Force the pancreas to release more insulin (sulfonylureas)
- Push glucose into storage (insulin)
- Reduce liver glucose output (metformin)
- Dump glucose out through urine (SGLT2 inhibitors)
- Suppress appetite (GLP‑1 agonists)
These strategies lower the number, but they don’t repair:
- insulin receptor sensitivity
- mitochondrial efficiency
- muscle glucose uptake
- inflammatory load
- circadian‑metabolic alignment
They manage the lab value, not the disease process.
The Uncomfortable Pattern No One Talks About
People often:
- need more medications over time
- progress to insulin
- accumulate complications
- lose muscle mass
- experience worsening metabolic flexibility
- see A1c rise again despite “good control”
Because the underlying physiology was never restored.
This is why someone can have “perfect numbers” and still develop neuropathy, fatty liver, kidney issues, or cardiovascular disease.
The glucose was controlled.
The disease was not.
The Real Myth
Diabetes medications don’t treat diabetes.
They treat glucose.
And glucose is just one downstream marker of a much bigger metabolic story.
So What Does Treat Diabetes?
This is where root‑cause physiology shines:
- building and preserving muscle mass
- improving mitochondrial function
- restoring circadian rhythm
- reducing inflammatory load
- repairing the gut‑brain axis
- optimizing nutrient status
- training metabolic flexibility
- addressing stress physiology
- supporting liver and muscle glucose handling
This is the work that reverses the disease process, not just the number
Clinically, they treat hyperglycemia. The disease is insulin resistance.
Most people think diabetes = high blood sugar.
Clinically, that’s not true.
Type 2 diabetes is a disease of impaired insulin signaling, mitochondrial dysfunction, and metabolic inflexibility.
Hyperglycemia is the late-stage biomarker of a system that’s been failing for years.
Let’s go deeper.
THE ACTUAL PATHOPHYSIOLOGY OF TYPE 2 DIABETES
Before glucose rises, the body goes through years of:
1. Hyperinsulinemia
The pancreas overproduces insulin to compensate for insulin resistance.
This is the first abnormality, not glucose.
2. Insulin receptor downregulation
Chronic high insulin causes:
- decreased insulin receptor density
- impaired GLUT4 translocation
- reduced muscle glucose uptake
- increased hepatic glucose output
This is the core defect.
3. Mitochondrial dysfunction
Mitochondria lose the ability to oxidize fatty acids efficiently.
This leads to:
- intramyocellular lipid accumulation
- DAG + ceramide buildup
- PKC activation
- further insulin signaling impairment
This is the biochemical engine of insulin resistance.
4. Metabolic inflexibility
The body loses the ability to switch between glucose and fat oxidation.
This is why people feel:
- energy crashes
- carb cravings
- post-meal fatigue
By the time glucose rises, the metabolic house has been on fire for years.
WHAT DIABETES MEDICATIONS ACTUALLY DO (CLINICALLY + MECHANISTICALLY)
1. Metformin
Mechanism:
- inhibits mitochondrial complex I
- reduces hepatic gluconeogenesis
- increases AMP/ATP ratio which activates AMPK
- modestly improves peripheral glucose uptake
What it doesn’t do:
- repair insulin receptor signaling
- restore mitochondrial function
- reverse metabolic inflexibility
It lowers glucose by suppressing liver output, not by fixing the disease.
2. Sulfonylureas (glipizide, glyburide)
Mechanism:
- force pancreatic beta cells to secrete more insulin
- independent of glucose levels
Clinical reality:
- accelerate beta-cell burnout
- worsen hyperinsulinemia
- increase weight gain
- increase hypoglycemia risk
They push the failing organ harder.
3. Insulin therapy
Mechanism:
- drives glucose into cells
- suppresses hepatic glucose production
Clinical reality:
- increases adipogenesis
- increases hepatic lipogenesis
- worsens weight gain
- increases hyperinsulinemia
- does not improve insulin sensitivity
You get better glucose numbers with worse metabolic health.
4. SGLT2 inhibitors
Mechanism:
- force glucose excretion through urine
Clinical reality:
- do not improve insulin signaling
- do not improve mitochondrial function
- risk of euglycemic DKA
- dehydration + electrolyte shifts
They remove glucose without touching the disease.
5. GLP‑1 agonists
Mechanism:
- suppress appetite
- slow gastric emptying
- reduce glucagon
- modestly reduce hepatic glucose output
Clinical reality:
- do not repair insulin receptor function
- do not restore metabolic flexibility
- cause muscle loss which worsens long-term insulin resistance
- metabolic rebound after discontinuation
They reduce intake, not dysfunction.
THE CLINICAL PATTERN THAT PROVES THE MYTH IS FALSE
If diabetes meds treated diabetes, we would see:
- fewer complications
- less progression
- less medication stacking
- less insulin dependence
- improved metabolic flexibility
But clinically, we see the opposite:
- A1c improves
- glucose improves
- but insulin resistance worsens
- medications escalate
- complications accumulate
Because the underlying physiology is untouched.
THE REAL DISEASE IS NOT HYPERGLYCEMIA IT’S INSULIN RESISTANCE.
And insulin resistance lives in:
- skeletal muscle
- liver
- adipose tissue
- mitochondria
- inflammatory pathways
- circadian biology
- nutrient signaling
- autonomic balance
Glucose is the last thing to break.
WHAT ACTUALLY TREATS DIABETES (CLINICALLY + MECHANISTICALLY)
1. Increasing skeletal muscle mass
More muscle = more GLUT4 = more glucose disposal.
2. Improving mitochondrial function
Better fat oxidation = less lipid accumulation = restored insulin signaling.
3. Reducing inflammation
Lower TNF‑α, IL‑6, CRP = improved insulin receptor function.
4. Restoring circadian rhythm
Insulin sensitivity is circadian.
Misalignment = metabolic dysfunction.
5. Improving nutrient signaling
Magnesium, chromium, omega‑3s, protein → insulin receptor cofactors.
6. Repairing the gut‑brain axis
GLP‑1, PYY, ghrelin, vagal tone → metabolic regulation.
7. Reducing hepatic fat
Less liver fat = less hepatic glucose output.
8. Training metabolic flexibility
Fasting + feeding cycles
Carb + fat oxidation cycles
Movement + recovery cycles
This is the physiology medications cannot replicate.
FOLLOW THE MONEY: The Diabetes Economy
Type 2 diabetes is not just a disease.
It’s a revenue stream, one of the most profitable chronic‑disease markets in the world.
And the financial incentives align perfectly with treatments that manage glucose but never repair insulin resistance.
Let’s map it out.
1. The Diabetes Market Is Built on Recurring Revenue
Chronic diseases are profitable because they require:
- daily meds
- lifelong monitoring
- repeat labs
- escalating treatment
- complication management
- hospitalizations
- devices and supplies
A cured patient is a lost customer.
A controlled glucose number with ongoing insulin resistance is the ideal customer.
2. Medications That Fix the Number (Not the Disease) Are the Most Lucrative
The highest‑earning diabetes drugs are the ones that:
- must be taken indefinitely
- escalate over time
- require combination therapy
- create downstream complications that require more care
Insulin alone is a multi‑billion‑dollar annual market.
Add metformin, SGLT2 inhibitors, GLP‑1s, sulfonylureas, and the stack becomes enormous.
None of these restore metabolic health.
All of them guarantee long‑term dependence.
3. Complications Are a Financial Engine
When insulin resistance progresses, it drives:
- neuropathy
- kidney disease
- cardiovascular disease
- fatty liver
- retinopathy
- amputations
- dialysis
- hospitalizations
Each complication is a new revenue line.
Clinically tragic.
Economically powerful.
4. The System Rewards Glucose Control, Not Metabolic Repair
Insurance reimburses for:
- A1c targets
- medication adherence
- glucose monitoring
- complication management
Insurance does not reimburse for:
- muscle mass restoration
- mitochondrial repair
- nutrition
- circadian alignment
- stress physiology
- metabolic flexibility training
So the system pays for the marker, not the mechanism.
And what gets paid for gets done.
5. The Most Effective Interventions Are the Least Profitable
The things that actually reverse insulin resistance:
- strength training
- nutrient optimization
- mitochondrial support
- circadian repair
- inflammation reduction
- metabolic flexibility training
These have:
- no patent
- no recurring revenue
- no billing code
- no shareholder upside
So they remain “alternative,” even though they’re physiologically foundational.
6. The Result: A Perfectly Designed Loop
1. Insulin resistance develops.
2. Glucose rises.
3. Meds lower glucose.
4. Insulin resistance worsens.
5. More meds are added.
6. Complications develop.
7. More treatments are needed.
Clinically: the patient gets sicker.
Economically: the system gets richer.
This is not conspiracy, is it? it’s surely incentive structure.
WHAT FUNCTIONAL MEDICINE DOES DIFFERENTLY
(Clinically, mechanistically, and economically)
Functional medicine is not “anti‑medication.”
It’s anti‑misidentifying the disease.
Where conventional care manages glucose, functional medicine targets the actual pathophysiology:
- insulin receptor dysfunction
- mitochondrial impairment
- metabolic inflexibility
- chronic inflammation
- circadian disruption
- nutrient‑hormone miscommunication
- loss of skeletal muscle glucose disposal
This is the upstream biology that medications don’t touch.
Let’s break down how functional medicine approaches diabetes at the mechanistic level.
1. Restores Insulin Signaling (the real disease)
Functional medicine focuses on:
- reducing intramyocellular lipids
- lowering DAG and ceramide accumulation
- decreasing PKC activation
- restoring IRS‑1/PI3K/AKT signaling
- improving GLUT4 translocation
This is the biochemical repair that reverses insulin resistance.
No diabetes medication does this.
2. Rebuilds Skeletal Muscle - the #1 Glucose Sink
Muscle is responsible for up to 80% of post‑meal glucose disposal.
Functional medicine prioritizes:
- resistance training
- protein adequacy
- mitochondrial biogenesis
- myokine signaling (IL‑6, irisin, BDNF)
- restoring GLUT4 density
This is why people’s glucose improves even before weight changes.
3. Repairs Mitochondrial Function
This is the heart of metabolic flexibility.
Functional medicine supports:
- fatty acid oxidation
- mitochondrial uncoupling
- electron transport chain efficiency
- AMPK activation
- NAD⁺ regeneration
- reduction of oxidative stress
When mitochondria work, insulin resistance reverses.
4. Rebuilds Circadian‑Metabolic Alignment
Insulin sensitivity is circadian.
Functional medicine addresses:
- meal timing
- light exposure
- sleep architecture
- cortisol rhythm
- melatonin‑insulin crosstalk
This alone can shift fasting glucose dramatically.
5. Repairs the Gut‑Brain‑Pancreas Axis
Functional medicine works on:
- GLP‑1 and PYY signaling
- vagal tone
- microbiome composition
- endotoxin load (LPS)
- gut permeability
- inflammatory cytokines
This is metabolic regulation at the neural‑hormonal level.
6. Optimizes Nutrient Signaling
Insulin signaling requires cofactors:
- magnesium
- chromium
- zinc
- omega‑3s
- B vitamins
- amino acids
Functional medicine restores the biochemical environment insulin needs to work.
7. Reduces Hepatic Fat (the driver of fasting glucose)
Functional medicine targets:
- de novo lipogenesis
- hepatic mitochondrial overload
- fructose burden
- inflammatory signaling
- adipose tissue lipolysis
When liver fat drops, fasting glucose normalizes.
8. Trains Metabolic Flexibility
Functional medicine uses:
- fed/fasted cycling
- carb periodization
- movement snacks
- post‑meal walking
- cold/heat exposure
- aerobic + resistance synergy
This retrains the metabolic system to switch fuels again.
AND HERE’S THE ECONOMIC TRUTH
Functional medicine is the only model that:
- reduces medication dependence
- reduces complication risk
- reduces long‑term cost
- reduces disease progression
- reduces system revenue
It’s not profitable for the healthcare system.
But it’s profoundly effective for the human body.
THE REAL CONTRAST
Conventional medicine manages glucose.
Functional medicine restores metabolic health.
One treats the number.
The other treats the disease.
1
2 comments
MEDICATION MONDAY - MYTH: DIABETES MEDICATIONS TREAT DIABETES
skool.com/simcha-healthcare-3222
What happens when your body begins to fail, and no one can tell you why? What happens when you're sick & your doctor tells you everything is normal?
Leaderboard (30-day)
1
🔥
+41
2
🔥
+24
3
🔥
+9
4
+8
5
+8
Powered by